nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Dermatitis acneiform—Vandetanib—thyroid cancer	0.0393	0.087	CcSEcCtD
Fludrocortisone—Impaired healing—Vandetanib—thyroid cancer	0.031	0.0687	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0294	0.0563	CbGpPWpGaD
Fludrocortisone—NR3C2—Preimplantation Embryo—NKX2-1—thyroid cancer	0.0278	0.0533	CbGpPWpGaD
Fludrocortisone—NR3C2—Preimplantation Embryo—TCF7L1—thyroid cancer	0.0245	0.0469	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—NCOA4—thyroid cancer	0.0242	0.0464	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0205	0.0393	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—NCOA4—thyroid cancer	0.0179	0.0343	CbGpPWpGaD
Fludrocortisone—Glaucoma—Vandetanib—thyroid cancer	0.0178	0.0395	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—THRB—thyroid cancer	0.0173	0.0331	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0172	0.0329	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.0156	0.0298	CbGpPWpGaD
Fludrocortisone—Cataract—Vandetanib—thyroid cancer	0.0141	0.0312	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0137	0.0261	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.0131	0.0251	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.0131	0.025	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0125	0.0239	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0122	0.0234	CbGpPWpGaD
Fludrocortisone—Neoplasm—Vandetanib—thyroid cancer	0.0121	0.0269	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0104	0.0198	CbGpPWpGaD
Fludrocortisone—Cardiomegaly—Epirubicin—thyroid cancer	0.00917	0.0203	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L1—thyroid cancer	0.00879	0.0168	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.00862	0.0165	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.00862	0.0165	CbGpPWpGaD
Fludrocortisone—Cardiomegaly—Doxorubicin—thyroid cancer	0.00849	0.0188	CcSEcCtD
Fludrocortisone—Pancreatitis—Vandetanib—thyroid cancer	0.00826	0.0183	CcSEcCtD
Fludrocortisone—Neoplasm—Sorafenib—thyroid cancer	0.00819	0.0181	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00789	0.0151	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Vandetanib—thyroid cancer	0.0076	0.0168	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—RXRA—thyroid cancer	0.00734	0.014	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00725	0.0161	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00703	0.0135	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Vandetanib—thyroid cancer	0.00678	0.015	CcSEcCtD
Fludrocortisone—Haemorrhage—Vandetanib—thyroid cancer	0.00674	0.0149	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—thyroid cancer	0.00637	0.0141	CcSEcCtD
Fludrocortisone—Mood swings—Sorafenib—thyroid cancer	0.00623	0.0138	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RET—thyroid cancer	0.006	0.0115	CbGpPWpGaD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.00596	0.0114	CbGpPWpGaD
Fludrocortisone—Hypernatraemia—Doxorubicin—thyroid cancer	0.00589	0.013	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0058	0.0111	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00569	0.0109	CbGpPWpGaD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—thyroid cancer	0.00563	0.0125	CcSEcCtD
Fludrocortisone—AR—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00562	0.0108	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00558	0.0107	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Sorafenib—thyroid cancer	0.00557	0.0123	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00557	0.0107	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00544	0.0104	CbGpPWpGaD
Fludrocortisone—Optic neuritis—Epirubicin—thyroid cancer	0.00544	0.012	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—thyroid cancer	0.00521	0.0115	CcSEcCtD
Fludrocortisone—Convulsion—Vandetanib—thyroid cancer	0.00509	0.0113	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	0.00508	0.00973	CbGpPWpGaD
Fludrocortisone—Hypertension—Vandetanib—thyroid cancer	0.00507	0.0112	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—thyroid cancer	0.00504	0.0111	CcSEcCtD
Fludrocortisone—Oedema—Vandetanib—thyroid cancer	0.00479	0.0106	CcSEcCtD
Fludrocortisone—Infection—Vandetanib—thyroid cancer	0.00476	0.0105	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—thyroid cancer	0.00463	0.00887	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—HIF1A—thyroid cancer	0.0046	0.0088	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Sorafenib—thyroid cancer	0.00457	0.0101	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00455	0.00872	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Sorafenib—thyroid cancer	0.00455	0.0101	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—thyroid cancer	0.00452	0.01	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.0044	0.00842	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00436	0.00966	CcSEcCtD
Fludrocortisone—Insomnia—Vandetanib—thyroid cancer	0.00433	0.00959	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00427	0.00817	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00423	0.0081	CbGpPWpGaD
Fludrocortisone—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00418	0.00926	CcSEcCtD
Fludrocortisone—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00414	0.00793	CbGpPWpGaD
Fludrocortisone—Glycosuria—Epirubicin—thyroid cancer	0.00413	0.00915	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—thyroid cancer	0.00407	0.00901	CcSEcCtD
Fludrocortisone—Erythema—Sorafenib—thyroid cancer	0.00396	0.00877	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00387	0.00741	CbGpPWpGaD
Fludrocortisone—Glycosuria—Doxorubicin—thyroid cancer	0.00382	0.00846	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—thyroid cancer	0.00381	0.00843	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—thyroid cancer	0.00376	0.00833	CcSEcCtD
Fludrocortisone—NR3C2—saliva-secreting gland—thyroid cancer	0.00375	0.145	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00371	0.0071	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00368	0.00704	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00366	0.00701	CbGpPWpGaD
Fludrocortisone—Amenorrhoea—Doxorubicin—thyroid cancer	0.00352	0.0078	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.00352	0.00673	CbGpPWpGaD
Fludrocortisone—Asthenia—Vandetanib—thyroid cancer	0.00344	0.00761	CcSEcCtD
Fludrocortisone—Hypertension—Sorafenib—thyroid cancer	0.00342	0.00757	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.00338	0.00648	CbGpPWpGaD
Fludrocortisone—Myalgia—Sorafenib—thyroid cancer	0.00337	0.00746	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00326	0.00624	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Sorafenib—thyroid cancer	0.00323	0.00715	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.00323	0.00618	CbGpPWpGaD
Fludrocortisone—Infection—Sorafenib—thyroid cancer	0.00321	0.00711	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—thyroid cancer	0.00318	0.00704	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.00314	0.00601	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.00308	0.00589	CbGpPWpGaD
Fludrocortisone—Oesophagitis—Epirubicin—thyroid cancer	0.00306	0.00677	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—thyroid cancer	0.00304	0.00674	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—thyroid cancer	0.00303	0.0067	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—thyroid cancer	0.00303	0.0067	CcSEcCtD
Fludrocortisone—Headache—Vandetanib—thyroid cancer	0.003	0.00664	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00294	0.00652	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—thyroid cancer	0.00294	0.00651	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00293	0.00561	CbGpPWpGaD
Fludrocortisone—NR3C2—trachea—thyroid cancer	0.0029	0.112	CbGeAlD
Fludrocortisone—Oesophagitis—Doxorubicin—thyroid cancer	0.00283	0.00627	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00281	0.00623	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00281	0.00539	CbGpPWpGaD
Fludrocortisone—Thrombophlebitis—Epirubicin—thyroid cancer	0.00281	0.00621	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—thyroid cancer	0.0028	0.0062	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—thyroid cancer	0.0028	0.0062	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—thyroid cancer	0.00279	0.00618	CcSEcCtD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00278	0.00532	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Epirubicin—thyroid cancer	0.00272	0.00601	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00268	0.00593	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0026	0.00575	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00258	0.00572	CcSEcCtD
Fludrocortisone—NR3C1—neck—thyroid cancer	0.00258	0.0997	CbGeAlD
Fludrocortisone—Urticaria—Sorafenib—thyroid cancer	0.00257	0.00568	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.00254	0.00485	CbGpPWpGaD
Fludrocortisone—Purpura—Epirubicin—thyroid cancer	0.00252	0.00558	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—thyroid cancer	0.00251	0.00556	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00251	0.00556	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00248	0.00549	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00247	0.00474	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—THRB—thyroid cancer	0.00245	0.00468	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.00244	0.00467	CbGpPWpGaD
Fludrocortisone—Affect lability—Epirubicin—thyroid cancer	0.00239	0.0053	CcSEcCtD
Fludrocortisone—Hypersensitivity—Sorafenib—thyroid cancer	0.00238	0.00527	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.00236	0.00451	CbGpPWpGaD
Fludrocortisone—Purpura—Doxorubicin—thyroid cancer	0.00233	0.00516	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00232	0.00514	CcSEcCtD
Fludrocortisone—Asthenia—Sorafenib—thyroid cancer	0.00232	0.00513	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—thyroid cancer	0.0023	0.0051	CcSEcCtD
Fludrocortisone—NR3C2—thyroid gland—thyroid cancer	0.00229	0.0885	CbGeAlD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.00226	0.00432	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00222	0.00426	CbGpPWpGaD
Fludrocortisone—Affect lability—Doxorubicin—thyroid cancer	0.00221	0.0049	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.00216	0.00413	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.00216	0.00413	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Epirubicin—thyroid cancer	0.00214	0.00474	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—thyroid cancer	0.00213	0.00472	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—thyroid cancer	0.00211	0.00468	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.00208	0.00398	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Epirubicin—thyroid cancer	0.00206	0.00456	CcSEcCtD
Fludrocortisone—NR3C2—head—thyroid cancer	0.00203	0.0785	CbGeAlD
Fludrocortisone—Headache—Sorafenib—thyroid cancer	0.00202	0.00448	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00202	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—saliva-secreting gland—thyroid cancer	0.00201	0.0778	CbGeAlD
Fludrocortisone—Muscular weakness—Doxorubicin—thyroid cancer	0.00198	0.00439	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—thyroid cancer	0.00196	0.00433	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—thyroid cancer	0.00191	0.00422	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—thyroid cancer	0.00189	0.00419	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.00182	0.00348	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.00179	0.00342	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00176	0.00337	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00175	0.00388	CcSEcCtD
Fludrocortisone—AR—thyroid gland—thyroid cancer	0.0017	0.0655	CbGeAlD
Fludrocortisone—Haemoglobin—Epirubicin—thyroid cancer	0.00169	0.00374	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—thyroid cancer	0.00168	0.00372	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.00167	0.00319	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TPR—thyroid cancer	0.00165	0.00316	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.00161	0.00308	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TRIM33—thyroid cancer	0.00157	0.00301	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Doxorubicin—thyroid cancer	0.00156	0.00346	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—thyroid cancer	0.00156	0.00344	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—MEN1—thyroid cancer	0.00155	0.00297	CbGpPWpGaD
Fludrocortisone—NR3C1—trachea—thyroid cancer	0.00155	0.06	CbGeAlD
Fludrocortisone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.00155	0.00296	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00153	0.00293	CbGpPWpGaD
Fludrocortisone—AR—head—thyroid cancer	0.00151	0.0581	CbGeAlD
Fludrocortisone—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.0015	0.00287	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.0015	0.00286	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.00148	0.00283	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—thyroid cancer	0.00146	0.00324	CcSEcCtD
Fludrocortisone—NR3C2—lymph node—thyroid cancer	0.00142	0.055	CbGeAlD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.00136	0.00261	CbGpPWpGaD
Fludrocortisone—Erythema—Doxorubicin—thyroid cancer	0.00135	0.003	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00134	0.00256	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—thyroid cancer	0.00131	0.00291	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.00131	0.00252	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—thyroid cancer	0.00127	0.00281	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—thyroid cancer	0.00126	0.0028	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.00125	0.0024	CbGpPWpGaD
Fludrocortisone—Myalgia—Epirubicin—thyroid cancer	0.00125	0.00276	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00124	0.00237	CbGpPWpGaD
Fludrocortisone—NR3C1—thyroid gland—thyroid cancer	0.00123	0.0475	CbGeAlD
Fludrocortisone—Vertigo—Doxorubicin—thyroid cancer	0.00122	0.00269	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—thyroid cancer	0.00119	0.00264	CcSEcCtD
Fludrocortisone—Oedema—Epirubicin—thyroid cancer	0.00119	0.00264	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.00119	0.00228	CbGpPWpGaD
Fludrocortisone—Infection—Epirubicin—thyroid cancer	0.00119	0.00263	CcSEcCtD
Fludrocortisone—Convulsion—Doxorubicin—thyroid cancer	0.00117	0.0026	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—thyroid cancer	0.00117	0.00259	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—thyroid cancer	0.00115	0.00256	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—thyroid cancer	0.00115	0.00255	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.00114	0.00217	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—THRB—thyroid cancer	0.00114	0.00217	CbGpPWpGaD
Fludrocortisone—Oedema—Doxorubicin—thyroid cancer	0.0011	0.00245	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0011	0.00245	CcSEcCtD
Fludrocortisone—Infection—Doxorubicin—thyroid cancer	0.0011	0.00243	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.00109	0.00209	CbGpPWpGaD
Fludrocortisone—NR3C1—head—thyroid cancer	0.00109	0.0421	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00109	0.00241	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—thyroid cancer	0.00108	0.00239	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00107	0.00237	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00105	0.00202	CbGpPWpGaD
Fludrocortisone—AR—lymph node—thyroid cancer	0.00105	0.0407	CbGeAlD
Fludrocortisone—NR3C2—Gene Expression—RXRA—thyroid cancer	0.00104	0.00199	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.00101	0.00193	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00101	0.00223	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.001	0.00192	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.001	0.00192	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.001	0.00191	CbGpPWpGaD
Fludrocortisone—Insomnia—Doxorubicin—thyroid cancer	0.000999	0.00221	CcSEcCtD
Fludrocortisone—Urticaria—Epirubicin—thyroid cancer	0.000949	0.0021	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000927	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000905	0.00173	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.00089	0.0017	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—thyroid cancer	0.00088	0.00195	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—thyroid cancer	0.000878	0.00194	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000874	0.00167	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—THRB—thyroid cancer	0.000861	0.00165	CbGpPWpGaD
Fludrocortisone—Asthenia—Epirubicin—thyroid cancer	0.000857	0.0019	CcSEcCtD
Fludrocortisone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000814	0.0018	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.00081	0.00155	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—thyroid cancer	0.000793	0.00176	CcSEcCtD
Fludrocortisone—AR—Gene Expression—TPR—thyroid cancer	0.000767	0.00147	CbGpPWpGaD
Fludrocortisone—NR3C1—lymph node—thyroid cancer	0.000763	0.0295	CbGeAlD
Fludrocortisone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.00076	0.00145	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000759	0.00145	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000751	0.00144	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—thyroid cancer	0.000748	0.00166	CcSEcCtD
Fludrocortisone—AR—Gene Expression—MEN1—thyroid cancer	0.000721	0.00138	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000719	0.00138	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—thyroid cancer	0.000692	0.00153	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000671	0.00128	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—thyroid cancer	0.000656	0.00126	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000633	0.00121	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000608	0.00116	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000596	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TPR—thyroid cancer	0.000582	0.00111	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000547	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000503	0.000964	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RXRA—thyroid cancer	0.000482	0.000923	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.00048	0.000918	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RXRA—thyroid cancer	0.000366	0.0007	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—thyroid cancer	0.000305	0.000583	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—thyroid cancer	0.000259	0.000497	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—thyroid cancer	0.000231	0.000442	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—thyroid cancer	0.00012	0.00023	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—thyroid cancer	9.13e-05	0.000175	CbGpPWpGaD
